聯交所:現徵求有意成為上市覆核委員會成員申請
港交所(00388.HK)旗下聯交所上市提名委員會現徵求有意為聯交所上市覆核委員會,及GEM上市覆核委員會服務的人士的申請。
目前上市覆核委員會的成員有26人,當中最少6人是投資者代表,其餘成員須足以代表上市發行人及市場各界人士。目前,上市覆核委員會有5名成員成為擔任委員會主席的人選,其中一人會負責主持由上市覆核委員會審理的覆核聆訊。
若獲委任,上市覆核委員會成員的任期將由2024年7月左右起計約12個月。申請人應預期每年會有約30個上市覆核委員會會議,而委員會成員須出席其中大約半數。就上市覆核委員會成員出席覆核會議、以及他們為每次會議所作準備,聯交所現時會向上市委員會成員支付定額酬金每年10萬元,每位主席為每年12.5萬元。
有關申請須於2024年4月8日或之前提交。入圍的申請人將在今年第二季收到會面通知。(ca/k)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.